Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Ireland

Marie Skłodowska-Curie Action · Running

EDICT Advancing Equity, Diversity and Inclusion in Clinical Trials

Coordinator
University of Galway, Ireland
Runs
1 March 2026 to 28 February 2030
Status
Running
EU funding
€4.3m
Total cost
—
Partners
26 organisations in 12 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101226601

What the project is doing

In the project's own words, from its summary on CORDIS.

“Advancing Equity, Diversity, and Inclusion in Clinical Trials” (EDICT) establishes an innovative Doctoral Network to transform how equity, diversity, and inclusion (EDI) principles are embedded in clinical trials across Europe. While clinical trials are essential for advancing medical knowledge, systematic exclusion of diverse populations undermines scientific validity and limits healthcare impact. EDICT will train the next generation of research leaders, equipped with specialised methodological expertise and practical skills to transform how clinical trials are designed and conducted, ensuring meaningful representation of diverse populations.

Leveraging expertise from multiple sectors—including academia, the pharmaceutical and MedTech industries, patient advocacy, regulatory bodies, trial networks, science communication, and evidence production—EDICT will support 16 (14 EU; 2 Swiss) doctoral candidates in developing solutions that enhance recruitment, improve data inclusivity, and ensure that trial outcomes are representative of broader population needs. The network will deliver concrete EDI innovations, including standardised metrics for measuring trial diversity, AI-powered tools for detecting recruitment bias, culturally-adapted consent processes, and implementation frameworks.

These outputs will transform how EDI is implemented across the clinical trials ecosystem. Through structured mobility between interdisciplinary academic, industry and policy environments, doctoral candidates will develop comprehensive expertise across four key domains: standardised measurement of trial diversity, innovative EDI methodologies, practical implementation tools, and frameworks for systemic change. EDICT will establish a permanent network of EDI champions, driving sustainable improvement in clinical trial inclusivity while advancing Europe's capacity to conduct equitable, representative, and scientifically robust health research.

Topics

Who is involved

OrganisationCityCountryRole
University of GalwayGalwayIrelandCoordinator
The SynergistBruxelles / BrusselBelgiumAssociatedpartner
Bruyere Research InstituteOttawaCanadaAssociatedpartner
University of OttawaOttawaCanadaAssociatedpartner
F. Hoffmann-La Roche AGBaselSwitzerlandAssociatedpartner
Universitat BaselBaselSwitzerlandAssociatedpartner
Aarhus UniversitetAarhus CDenmarkAssociatedpartner
Fundacion Para La Investigacion Biomedica Del Hospital Universiatrio La PazMadridSpainParticipant
Servicio Madrileno De SaludMadridSpainAssociatedpartner
Universidad Autonoma De MadridMadridSpainAssociatedpartner
Ecrin European Clinical Research Infrastructure NetworkParisFranceAssociatedpartner
Universite Paris CiteParisFranceParticipant
Hrvatsko Katolicko SveucilisteZagrebCroatiaParticipant
Sveuciliste U Splitu Medicinski FakultetSplitCroatiaAssociatedpartner
Agentschap College Ter Beoordeling Van GeneesmiddelenUtrechtNetherlandsAssociatedpartner
Julius Clinical Research BVZeistNetherlandsAssociatedpartner
Universitair Medisch Centrum UtrechtUtrechtNetherlandsParticipant
Universiteit UtrechtUtrechtNetherlandsAssociatedpartner
WcnUtrechtNetherlandsAssociatedpartner
Uppsala UniversitetUppsalaSwedenAssociatedpartner
Medtronic LtdWatfordUnited KingdomAssociatedpartner
Sense About ScienceLondonUnited KingdomAssociatedpartner
The University Court of the University of AberdeenAberdeenUnited KingdomParticipant
The University of LiverpoolLiverpoolUnited KingdomAssociatedpartner
Medtronic, Inc.MinneapolisUnited StatesAssociatedpartner
Pfizer IncNew York CityUnited StatesAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI